ZYMEWORKS
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. The company is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases. Zymeworks' approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. Using this approach Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization. It was founded in 2004 and headquartered in Vancouver, British Columbia.
ZYMEWORKS
Industry:
Biotechnology Medical Therapeutics
Founded:
2004-04-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.zymeworks.com
Total Employee:
251+
Status:
Active
Contact:
(604)678-1388
Total Funding:
883.66 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content BootstrapCDN ReCAPTCHA V2 Microsoft Gravity Forms Java EE Amazon Oregon Region Amazon Elastic Load Balancing Akamai Hosted
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Magenta Therapeutics
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-03-22 | Kairos Therapeutics | Kairos Therapeutics acquired by Zymeworks | N/A |
Investors List
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Zymeworks
Business Development Bank of Canada
Business Development Bank of Canada investment in Post-IPO Equity - Zymeworks
Amplitude Venture Capital
Amplitude Venture Capital investment in Post-IPO Equity - Zymeworks
Wells Fargo Securities Canada
Wells Fargo Securities Canada investment in Post-IPO Equity - Zymeworks
Raymond James
Raymond James investment in Post-IPO Equity - Zymeworks
Paradigm Capital
Paradigm Capital investment in Post-IPO Equity - Zymeworks
Citigroup Global Markets Canada Inc
Citigroup Global Markets Canada Inc investment in Post-IPO Equity - Zymeworks
MTS Health Partners
MTS Health Partners investment in Post-IPO Equity - Zymeworks
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series A - Zymeworks
Northleaf Capital Partners
Northleaf Capital Partners investment in Series A - Zymeworks
Key Employee Changes
Official Site Inspections
http://www.zymeworks.com Semrush global rank: 2.65 M Semrush visits lastest month: 6.63 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zymeworks"
Zymeworks - Wikipedia
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds accordi…See details»
Who We Are - Zymeworks
Who We Are Zymeworks is a global biotechnology company developing novel, multifunctional therapeutics to address difficult-to-treat cancers and other serious diseases. We are driven by …See details»
Zymeworks - Crunchbase Company Profile & Funding
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. The company is committed to developing best-in-class protein therapeutics for the treatment of …See details»
Zymeworks Inc. - BioTalent Canada
Zymeworks is a global biotechnology company developing novel, multifunctional therapeutics to address difficult-to-treat cancers and other serious diseases. We are driven by our mission to …See details»
Zymeworks Company Profile | Management and Employees List
SQL International Organization for Standardization . C# Microsoft . CSS World Wide Web Consortium . Perl Perl.com . JavaScript Netsweeper . Python Python Software Foundation . …See details»
Zymeworks Inc. (ZYME) Company Profile & Facts - Yahoo Finance
See the company profile for Zymeworks Inc. (ZYME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Zymeworks Inc. - LinkedIn
Zymeworks was honored to attend the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 in Houston! It was an inspiring few days connecting with leading experts in cancer immunotherapy ...See details»
Zymeworks Inc. (ZYME) Company Profile & Facts - Yahoo Finance
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product …See details»
Investor Relations | Zymeworks Inc.
Oct 31, 2024 Zymeworks Announces Participation in Upcoming Investor Conferences. VANCOUVER, British Columbia , Nov. 21, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. …See details»
Zymeworks Announces Additional Leadership Appointments
Jan 4, 2024 For information about Zymeworks, visit www.zymeworks.com and follow @ZymeworksInc on X. Cautionary Note Regarding Forward-Looking Statements This press …See details»
Leadership - Zymeworks
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
Our Science - Zymeworks
Zymeworks is an industry leader in multispecific research and the use of this technology in developing therapeutics targeting areas of high unmet medical need. Our clinically validated …See details»
Careers - Zymeworks
Careers Better together for a better world By bringing people together in purpose, we can solve the world’s most challenging medical problems. Using our innovative approach to …See details»
Zymeworks Company Profile 2024: Stock Performance & Earnings
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its …See details»
What is Zymeworks? Company Culture, Mission, Values
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Our fully integrated R&D engine from target …See details»
Zymeworks Announces New Director Nominee
Oct 16, 2023 Zymeworks Media Contact: Diana Papove Director, Corporate Communications [email protected] (604) 678-1388. Zymeworks Investor Contact: Shrinal Inamdar …See details»
Zymeworks Announces Plan to Become a Delaware Corporation
Jul 15, 2022 In connection with the proposed Redomicile, Zymeworks will cause its subsidiary Zymeworks Delaware Inc., a Delaware corporation (“New Zymeworks”), to file a registration …See details»
Patients - Zymeworks
Patients We are focused on one goal: Advancing novel therapeutics with the potential to make a meaningful difference in the lives of patients with difficult-to-treat cancers and other serious …See details»
Zymeworks Shares Rise 8.3% After Licensed Cancer ... - MarketWatch
Zymeworks first developed the molecule, and in 2022 entered a license and collaboration deal with Jazz for exclusive development and commercialization rights to the compound in most …See details»
Technology — Zymeworks
Our Technology Engineering Fit-for-Purpose Biotherapeutics Our technology leverages Zymeworks’ industry leading expertise in the fields of protein engineering and drug chemistry …See details»